Sana Biotechnology Inc (SANA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 124,806 | 80,030 | N/A | N/A |
| Marketable Securities | 253,458 | 58,952 | N/A | N/A |
| TOTAL | $384,467 | $144,263 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 46,775 | 27,911 | N/A | N/A |
| Investments And Advances | 33,731 | 0 | 0 | 0 |
| Intangibles | 199,822 | 199,822 | 0 | 0 |
| Other Non-Current Assets | 65,501 | 43,196 | 0 | 0 |
| TOTAL | $345,829 | $270,929 | $N/A | $N/A |
| Total Assets | $730,296 | $415,192 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 2,253 | 0 | 0 | 0 |
| Accrued Expenses | 25,486 | 17,981 | N/A | N/A |
| TOTAL | $31,451 | $19,323 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 1,120,029 | 538,411 | 0 | 0 |
| TOTAL | $1,120,029 | $538,411 | $N/A | $N/A |
| Total Liabilities | $1,151,480 | $557,734 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 2 | 1 | N/A | N/A |
| Retained earnings | -429,432 | -144,127 | N/A | N/A |
| Other shareholders' equity | 30 | 26 | 0 | 0 |
| TOTAL | $-421,184 | $-142,542 | $N/A | $N/A |
| Total Liabilities And Equity | $730,296 | $415,192 | $0 | $0 |